FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner The Amino zing World of Peptide Regulation ArentFox Schiff Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York